310 related articles for article (PubMed ID: 28477167)
1. Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy.
Oda S; Utsunomiya D; Morita K; Nakaura T; Yuki H; Kidoh M; Hirata K; Taguchi N; Tsuda N; Shiraishi S; Namimoto T; Hirakawa K; Takashio S; Izumiya Y; Yamamuro M; Hokimoto S; Tsujita K; Ueda M; Yamashita T; Ando Y; Yamashita Y
Eur Radiol; 2017 Nov; 27(11):4631-4638. PubMed ID: 28477167
[TBL] [Abstract][Full Text] [Related]
2. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
Cui Q; Yu J; Shen W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
[TBL] [Abstract][Full Text] [Related]
3. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis.
Pan JA; Kerwin MJ; Salerno M
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1299-1310. PubMed ID: 32498919
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
[TBL] [Abstract][Full Text] [Related]
5. Native T1 mapping to detect extent of acute and chronic myocardial infarction: comparison with late gadolinium enhancement technique.
Dastidar AG; Harries I; Pontecorboli G; Bruno VD; De Garate E; Moret C; Baritussio A; Johnson TW; McAlindon E; Bucciarelli-Ducci C
Int J Cardiovasc Imaging; 2019 Mar; 35(3):517-527. PubMed ID: 30357547
[TBL] [Abstract][Full Text] [Related]
6. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
[TBL] [Abstract][Full Text] [Related]
7. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
Karamitsos TD; Piechnik SK; Banypersad SM; Fontana M; Ntusi NB; Ferreira VM; Whelan CJ; Myerson SG; Robson MD; Hawkins PN; Neubauer S; Moon JC
JACC Cardiovasc Imaging; 2013 Apr; 6(4):488-97. PubMed ID: 23498672
[TBL] [Abstract][Full Text] [Related]
8. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
[TBL] [Abstract][Full Text] [Related]
9. Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping.
Pradella S; Grazzini G; Brandani M; Calistri L; Nardi C; Mori F; Miele V; Colagrande S
Eur Radiol; 2019 Mar; 29(3):1546-1554. PubMed ID: 30088066
[TBL] [Abstract][Full Text] [Related]
10. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
[TBL] [Abstract][Full Text] [Related]
11. Regional amyloid distribution and impact on mortality in light-chain amyloidosis: a T1 mapping cardiac magnetic resonance study.
Wan K; Li W; Sun J; Xu Y; Wang J; Liu H; Dong Y; Cheng W; Zhang Q; Zeng Z; Zhou X; Han Y; Chen Y
Amyloid; 2019 Mar; 26(1):45-51. PubMed ID: 30931628
[TBL] [Abstract][Full Text] [Related]
12. Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis.
Kim JY; Hong YJ; Han K; Lee HJ; Hur J; Kim YJ; Choi BW
Korean J Radiol; 2021 Jun; 22(6):880-889. PubMed ID: 33686816
[TBL] [Abstract][Full Text] [Related]
13. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar.
Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M
Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374
[TBL] [Abstract][Full Text] [Related]
14. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
[TBL] [Abstract][Full Text] [Related]
15. Quantitative T1 Mapping for Detecting Microvascular Obstruction in Reperfused Acute Myocardial Infarction: Comparison with Late Gadolinium Enhancement Imaging.
Shin JM; Choi EY; Park CH; Han K; Kim TH
Korean J Radiol; 2020 Aug; 21(8):978-986. PubMed ID: 32677382
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Compacted Myocardial Abnormalities by Cardiac Magnetic Resonance With Native T1 Mapping in Left Ventricular Non-Compaction Patients - A Comparison With Late Gadolinium Enhancement.
Zhou H; Lin X; Fang L; Zhao X; Ding H; Chen W; Xu R; Bai X; Wang Y; Fang Q
Circ J; 2016 Apr; 80(5):1210-6. PubMed ID: 27010628
[TBL] [Abstract][Full Text] [Related]
17. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.
Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
J Cardiovasc Magn Reson; 2014 May; 16(1):36. PubMed ID: 24886708
[TBL] [Abstract][Full Text] [Related]
18. A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis.
Chamling B; Bietenbeck M; Drakos S; Korthals D; Vehof V; Stalling P; Meier C; Yilmaz A
Sci Rep; 2022 Dec; 12(1):21755. PubMed ID: 36526658
[TBL] [Abstract][Full Text] [Related]
19. Quantitative inversion time prescription for myocardial late gadolinium enhancement using T1-mapping-based synthetic inversion recovery imaging: reducing subjectivity in the estimation of inversion time.
Gassenmaier S; van der Geest RJ; Schoepf UJ; Suranyi P; Rehwald WG; De Cecco CN; Mastrodicasa D; Albrecht MH; De Santis D; Lesslie VW; Ruzsics B; Varga-Szemes A
Int J Cardiovasc Imaging; 2018 Jun; 34(6):921-929. PubMed ID: 29305739
[TBL] [Abstract][Full Text] [Related]
20. Non-contrast-enhanced T
Yanagisawa F; Amano Y; Tachi M; Inui K; Asai K; Kumita S
Magn Reson Med Sci; 2019 Jan; 18(1):12-18. PubMed ID: 29515087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
